IO Biotech Correlations
| IOBT Stock | USD 0.74 0.04 5.71% |
The current 90-days correlation between IO Biotech and Werewolf Therapeutics is 0.01 (i.e., Significant diversification). The correlation of IO Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
IO Biotech Correlation With Market
Significant diversification
The correlation between IO Biotech and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding IO Biotech and DJI in the same portfolio, assuming nothing else is changed.
Moving against IOBT Stock
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between IOBT Stock performing well and IO Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IO Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HOWL | 4.70 | (1.68) | 0.00 | (0.50) | 0.00 | 7.69 | 51.99 | |||
| SPRB | 41.87 | 21.50 | 2.68 | (1.93) | 5.16 | 16.49 | 1,395 | |||
| ACET | 3.72 | (0.67) | 0.00 | (0.85) | 0.00 | 6.59 | 35.48 | |||
| OTLK | 4.76 | 1.13 | 0.21 | (1.68) | 4.16 | 12.74 | 25.95 | |||
| CUE | 4.38 | (1.18) | 0.00 | (0.36) | 0.00 | 10.00 | 35.25 | |||
| KPTI | 3.35 | 0.08 | 0.03 | 0.13 | 3.82 | 8.24 | 16.03 | |||
| NRXP | 3.99 | (0.26) | 0.00 | (0.06) | 0.00 | 8.57 | 25.43 | |||
| INKT | 2.94 | (0.30) | 0.00 | (0.20) | 0.00 | 5.52 | 19.87 | |||
| OSTX | 2.87 | (0.70) | 0.00 | (0.26) | 0.00 | 5.42 | 16.39 |
IO Biotech Corporate Management
| MaiBritt Zocca | President, Founder | Profile | |
| Qasim MD | Chief Officer | Profile | |
| Faical Miyara | Chief Officer | Profile | |
| Brian CPA | Senior Officer | Profile | |
| Amy Sullivan | Chief Officer | Profile | |
| Anders Ljungqvist | Founder | Profile | |
| Brian Burkavage | Chief Officer | Profile |